CMP
MRK icon

Coston McIsaac & Partners’s Merck MRK Stock Holding History

Coston McIsaac & Partners’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.11M Buy
8,609
+5
+0.1% +$585 0.22% 67
2026
Q1 		$1.03M Sell
8,604
-817
-9% -$94.3K 0.23% 62
2025
Q4 		$991K Sell
9,421
-438
-4% -$41.1K 0.23% 67
2025
Q3 		$827K Buy
9,859
+43
+0.4% +$3.54K 0.2% 73
2025
Q2 		$777K Sell
9,816
-670
-6% -$53.3K 0.2% 76
2025
Q1 		$941K Buy
10,486
+207
+2% +$19.3K 0.27% 61
2024
Q4 		$1.02M Buy
10,279
+5
+0% +$515 0.3% 57
2024
Q3 		$1.17M Buy
10,274
+4
+0% +$475 0.33% 51
2024
Q2 		$1.27M Buy
10,270
+3
+0% +$386 0.4% 46
2024
Q1 		$1.35M Buy
10,267
+4
+0% +$493 0.43% 45
2023
Q4 		$1.12M Buy
10,263
+35
+0.3% +$3.63K 0.39% 48
2023
Q3 		$1.05M Sell
10,228
-86
-0.8% -$9.27K 0.4% 48
2023
Q2 		$1.19M Buy
10,314
+94
+0.9% +$10.7K 0.41% 53
2023
Q1 		$1.09M Buy
10,220
+124
+1% +$13.4K 0.4% 54
2022
Q4 		$1.12M Sell
10,096
-128
-1% -$13.1K 0.44% 52
2022
Q3 		$880K Buy
10,224
+5
+0% +$446 0.4% 51
2022
Q2 		$932K Buy
+10,219
New +$906K 0.56% 44

Other funds holding MRK

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Coston McIsaac & Partners's MRK Position: Q2 2026 in Review

Coston McIsaac & Partners increased its Merck (MRK) stake by 0.06% in Q2 2026, buying an estimated $585 and bringing the position to 8,609 shares worth $1.11M. The position accounts for 0.22% of the portfolio, ranked #67.

Coston McIsaac & Partners first reported a position in MRK in Q2 2022 and has held it in 17 quarters since. The position peaked at $1.35M in Q1 2024. 3,845 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Coston McIsaac & Partners held 8,609 shares of Merck worth $1.11M as of Q2 2026.
  • Coston McIsaac & Partners bought 5 Merck shares in Q2 2026, an estimated $585.
  • Merck made up 0.22% of Coston McIsaac & Partners's portfolio in Q2 2026, its #67 holding.
  • Coston McIsaac & Partners first reported a position in Merck in Q2 2022 and has held it in 17 quarters since.
  • Coston McIsaac & Partners's Merck position peaked at $1.35M in Q1 2024.
  • 3,845 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Coston McIsaac & Partners's 13F filing for Q2 2026, filed 12 Aug 2026.